Insurance professionals could help avert trauma, pain and remorse by helping clients construct a Plan B should they carry debt.
HOUSTON, Nov. 15, 2013 /PRNewswire/ -- Today, 21 institutional investors represented by Gibbs & Bruns LLP ("Institutional Investors") announced they have reached an agreement with JPMorgan under which JPMorgan will make a binding offer ("Offer") to the Trustees of 330 RMBS Trusts issued by JPMorgan, Bear Stearns and Chase to settle mortgage repurchase and servicing claims. The Institutional Investors support the agreement and have asked the Trustees to accept it. The Trusts included in the Offer are listed on Exhibit "A."
The Trustees will have until January 15, 2014 to accept the Offer, which may be extended pursuant to the terms of the Offer for an additional sixty days. The Offer includes the following key terms:
The Institutional Investors who are parties to the agreement are:
Pursuant to the agreement, the Institutional Investors have requested that the Trustees accept the Settlement. They have also agreed to use their reasonable best efforts to obtain court approval of the settlement, if the Trustees elect to accept the Settlement and seek a judicial instruction concerning their decision to do so. Attorneys' fees for the Institutional Investors counsel, Gibbs & Bruns, will be paid in addition to—and not out of—the Settlement Payment upon the latter of the Trustees' Acceptance or Final Court Approval, if a judicial instruction is sought.
Q: Who are the parties to the settlement?
A: JPMorgan has made a binding Offer to the RMBS Trustees of all of the RMBS Trusts listed on Exhibit "A." The Trustees who have received the offer are: Bank of New York Mellon, The Bank of New York Mellon Trust Company, Deutsche Bank National Trust Company, Deutsche Bank Trust Company Americas, HSBC Bank USA, N.A., Law Debenture Trust Company of New York, U.S. Bank N.A., Wilmington Trust Co., and Wells Fargo Bank, N.A., and/or separate or successor trustees for the RMBS Trusts appointed pursuant to court orders confirming their appointment or otherwise appointed. The Offer is being made pursuant to an agreement between JPMorgan and the Institutional Investors.
Q: What Trusts are involved in the proposed settlement?
A: There are 330 Trusts involved in the settlement. They are listed on Exhibit "A."
Q: Who are the parties to the tolling and forbearance agreement? When was it signed?
A: JPMorgan entered into the tolling and forbearance agreement with the RMBS Trustees as of November 6, 2013. The Trustee tolling and forbearance agreement relates back to and includes earlier tolling agreements with the Institutional Investors.
Q: What was the role of the 21 Institutional Investors?
A: The Institutional Investors include those who requested the Trustees open an investigation into potential mortgage repurchase and servicing claims held by the RMBS Trusts on December 15, 2011. The Institutional Investors, through their Steering Committee and their counsel, led the settlement negotiations. The Institutional Investors did not negotiate on behalf of the Trustees and the Trustees were not parties to the negotiations that led to the Offer. The Institutional Investors have requested that the Trustees enter into the settlement and will appear in court to support the settlement, should the Trustees elect to seek a judicial instruction concerning their decision to accept a settlement.
Q: Will the Institutional Investors benefit differently than other investors under the settlement?
A: No, they will not. Upon the latter of the Trustees' Acceptance or Final Court Approval, the Settlement Payment will be allocated by the Trustees' expert among the RMBS Trusts based on each Trust's then current and future expected collateral losses. Each RMBS Trust's allocable share of the settlement payment will flow down its payment waterfall in accordance with the governing documents for that Trust. The Institutional Investors will participate in the settlement, like every other investor, based on the terms of the payment waterfall.
Q: Will individual investors' securities claims be released in this settlement?
A: No, they will not. The settlement pertains only to the Trusts' repurchase and servicing claims. The Offer states specifically that, "The releases and waivers in Article III do not include any direct individual claims for securities fraud or other alleged disclosure violations ("Disclosure Claims") that an Investor may seek to assert based upon such Investor's purchase or sale of Securities." JPMorgan has reserved the right to assert that any payment made or benefit conferred under the settlement constitutes an offset or credit against or a reduction in the gross amount of an Investor's Disclosure Claim damages.
Q: Will third-party mortgage originators not affiliated with JPMorgan be released from repurchase obligations?
A: No. The Offer is limited to these 330 Trusts. The only parties whose liability to the Trusts will be released if the Offer is accepted are JPMorgan and its affiliates. If the Trusts hold repurchase claims against other parties, those claims are not released under this Offer.
Q: Are any Washington Mutual Trusts included in the Offer?
A: No. Trusts issued by Washington Mutual or its affiliates are not affected by this Offer and no claims belonging to those Trusts will be released.
Q: What are the changes in mortgage servicing for mortgage loans in the Trusts that will be implemented as a result of the settlement?
A: The agreement requires several changes in mortgage servicing of the mortgage loans in the Trusts. These changes include:
Q: How will the Trustees assess whether to accept the Settlement?
A: The Trustees will have sixty days to conduct a reasonable investigation of the Settlement and its terms. They may request a sixty day extension of this evaluation period under the terms of the Agreement.
The Trustees may request documents or other information from JPMorgan to conduct such diligence, may retain experts to assist them, and may conduct such other due diligence as they deem necessary to inform themselves concerning the Settlement. JPMorgan has agreed to use its commercially reasonable efforts to provide the Trustees promptly with the documents they reasonably require for their due diligence.
Q: Will the Trusts pay the costs of the Trustees' evaluation of the Settlement?
A: No. Pursuant to the Offer, JPMorgan will pay all reasonable and non-duplicative costs, fees and expenses the Trustees incur to evaluate the Settlement, the claims it resolves, and its terms. This payment will be on top of, not out of, the $4.5 billion cash settlement payment.
Q: When and how will the settlement payment be distributed?
A: The settlement payment will be distributed pursuant to a formula based on each accepting Trust's percentage share of total realized and unrealized losses. The timing of payment is not certain, as it depends upon a number of factors including: a) whether the Trustees accept the settlement, b) whether the Trustees elect to seek a judicial instruction concerning their decision to accept the settlement, and c) whether Final Court Approval, if sought, is granted.
Q: What is the allocation formula?
A: The settlement agreement specifies that the Trustees will retain a single financial expert to determine the then current and future expected net losses that have been and are expected to be borne by that Trust from its inception to its expected date of termination as a percentage of the sum of all such losses that are expected to be borne by all of the RMBS Trusts over the same time period.
For purposes of the loss allocation, losses associated with certain third-party originators in the JPMorgan multi-originator Trusts with prefixes JPALT, JPMAC, and JPMMT will be discounted to account for the fact that those trusts retain direct repurchase claims that could be asserted against those originators.
Q: How can interested investors learn more about the settlement?
A: All investors will receive a notice from the relevant Trustee(s) concerning the settlement terms.
ABOUT GIBBS & BRUNS LLPGibbs & Bruns LLP is a premier boutique law firm engaging in high-stakes business and commercial litigation. The firm is renowned for its signature lean trial teams and representation of both plaintiffs and defendants in complex matters, including significant securities and institutional investor litigation, director and officer liability, contract disputes, fraud and fiduciary claims, energy litigation, construction litigation, trust and estate litigation, antitrust litigation, legal and professional malpractice, and partnership disputes. For more information, visit www.gibbsbruns.com.
SOURCE Gibbs & Bruns LLP